284
views
0
recommends
+1 Recommend
0 collections
    4
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Current neural induction protocols in human ES cells (hESCs) rely on embryoid body formation, stromal feeder co-culture, or selective survival conditions; each strategy displaying significant drawbacks such as poorly defined culture conditions, protracted differentiation and low yield.

          Here we report that the synergistic action of two inhibitors of SMAD signaling, Noggin and SB431542, is sufficient for inducing rapid and complete neural conversion of hESCs under adherent culture conditions. Temporal fate analysis reveals a transient FGF5 + epiblast-like stage followed by PAX6 + neural cells competent of rosette formation. Initial cell density determines the ratio of CNS versus neural crest progeny. Directed differentiation of human iPSCs into midbrain dopamine and spinal motoneurons confirm robustness and general applicability of the novel induction protocol.

          Noggin/SB431542 based neural induction should greatly facilitate the use of hESC and hiPSCs in regenerative medicine and disease modeling and obviate the need for stromal feeder or embryoid body based protocols.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

          Successful reprogramming of differentiated human somatic cells into a pluripotent state would allow creation of patient- and disease-specific stem cells. We previously reported generation of induced pluripotent stem (iPS) cells, capable of germline transmission, from mouse somatic cells by transduction of four defined transcription factors. Here, we demonstrate the generation of iPS cells from adult human dermal fibroblasts with the same four factors: Oct3/4, Sox2, Klf4, and c-Myc. Human iPS cells were similar to human embryonic stem (ES) cells in morphology, proliferation, surface antigens, gene expression, epigenetic status of pluripotent cell-specific genes, and telomerase activity. Furthermore, these cells could differentiate into cell types of the three germ layers in vitro and in teratomas. These findings demonstrate that iPS cells can be generated from adult human fibroblasts.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Induced pluripotent stem cell lines derived from human somatic cells.

            Somatic cell nuclear transfer allows trans-acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state. We show that four factors (OCT4, SOX2, NANOG, and LIN28) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells. These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivatives of all three primary germ layers. Such induced pluripotent human cell lines should be useful in the production of new disease models and in drug development, as well as for applications in transplantation medicine, once technical limitations (for example, mutation through viral integration) are eliminated.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Reprogramming of human somatic cells to pluripotency with defined factors.

              Pluripotency pertains to the cells of early embryos that can generate all of the tissues in the organism. Embryonic stem cells are embryo-derived cell lines that retain pluripotency and represent invaluable tools for research into the mechanisms of tissue formation. Recently, murine fibroblasts have been reprogrammed directly to pluripotency by ectopic expression of four transcription factors (Oct4, Sox2, Klf4 and Myc) to yield induced pluripotent stem (iPS) cells. Using these same factors, we have derived iPS cells from fetal, neonatal and adult human primary cells, including dermal fibroblasts isolated from a skin biopsy of a healthy research subject. Human iPS cells resemble embryonic stem cells in morphology and gene expression and in the capacity to form teratomas in immune-deficient mice. These data demonstrate that defined factors can reprogramme human cells to pluripotency, and establish a method whereby patient-specific cells might be established in culture.
                Bookmark

                Author and article information

                Journal
                9604648
                20305
                Nat Biotechnol
                Nature biotechnology
                1087-0156
                1546-1696
                28 April 2009
                1 March 2009
                March 2009
                5 October 2009
                : 27
                : 3
                : 275-280
                Affiliations
                [1 ]Developmental Biology Program, Sloan-Kettering Institute, 1275 York Ave, New York, New York 10065, USA.
                [2 ]Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
                [3 ]Department of Neurosurgery, Sloan-Kettering Institute, 1275 York Ave, New York, New York 10065, USA.
                Author notes
                Correspondence: Dr. Lorenz Studer, Developmental Biology, 1275 York Ave, Box 256, New York, NY 10065, Phone: 212-639-6126, Fax: 212-717-3642, Email: studerl@ 123456mskcc.org

                Author Contributions

                S.M.C. and L.S. designed the study. E.P.P., M.T., L.S., and M.S. designed and generated the h-iPS clones. S.M.C. and L.S. analyzed the data and wrote the manuscript. S.M.C. and C.A.F. performed the experiments.

                Article
                nihpa93167
                10.1038/nbt.1529
                2756723
                19252484
                82705c10-4b74-48d4-be01-d59fad30f1b6
                History
                Funding
                Funded by: National Institute of Neurological Disorders and Stroke : NINDS
                Award ID: R01 NS052671-03 ||NS
                Categories
                Article

                Biotechnology
                Biotechnology

                Comments

                Comment on this article